Ipsen To Buy Five Products for $88M From Rival Sanofi

Feb. 14, 2017

Ipsen has reached an agreement to buy five consumer healthcare products from French rival Sanofi for approximately $88 million.

The deal was spurred by requirements from the European Commission to sell certain assets from a previous deal between Sanofi and the German Boehringer Ingelheim.

Ipsen are acquiring Buscopan, Suppositoria Glycerini, Mucothiol, Mucodyne, and Prontalgine, a pain treatment that has grown at double-digit rates over the last four years.

In January, Ipsen bought Merrimack pancreatic cancer drug ONIVYDE.

Read the Reuters report